United States · FDA National Drug Code directory
Posaconazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69238-1476_3f266ed7-06f9-48bf-a520-787aeb4e111c
- Product NDC
- 69238-1476
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Posaconazole
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221230
- Source listing expiry
- 20271231
Source-listed ingredients
- POSACONAZOLE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1476-3) · 69238-1476-3
- 60 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1476-6) · 69238-1476-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →